Ozanimod Hits Ulcerative Colitis Early

(MedPage Today) -- Just 1 week of full-dose ozanimod (Zeposia) was enough to bring symptom relief and biomarker improvement in patients with ulcerative colitis, a new analysis of placebo-controlled trial data indicated.
Differences in rectal bleeding...